Alzamend Neuro Inc
ALZN | NASDAQ
$1.93
-$0.01 (-0.52%)
Sep 22, 2026, 11:20 AM ET · Market open
Fiscal Year Period Ending | FY 2026 Apr 29, 2026 | FY 2025 Apr 29, 2025 | FY 2024 Apr 29, 2024 | FY 2023 Apr 29, 2023 | FY 2022 Apr 29, 2022 | FY 2021 Apr 29, 2021 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 710.69K | 3.95M | 376.05K | 5.14M | 14.06M | 1.93M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | 0 | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | 16.21K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.05M | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 1.76M | 4.18M | 455.24K | 5.84M | 14.41M | 2.91M |
Property-Plant & Equipment | 314.87K | 425.61K | 176.35K | 79.84K | 102.91K | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 314.87K | 425.61K | 176.35K | 79.84K | 102.91K | n/a |
Total Assets | 2.08M | 4.6M | 631.59K | 5.92M | 14.52M | 2.91M |
Account Payables | 1.35M | 634.76K | 2.93M | 2.87M | 1.16M | 503.59K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | 300.71K | n/a | n/a | 335.3K |
Other Current Liabilities | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 1.35M | 634.76K | 3.23M | 2.87M | 1.16M | 899.64K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | 0 | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | 0 | n/a | n/a | n/a |
Total Liabilities | 1.35M | 634.76K | 3.23M | 2.87M | 1.16M | 899.64K |
Total Debt | n/a | n/a | 300.71K | n/a | n/a | 335.3K |
Book Value | 733.21K | 3.97M | -2.59M | 3.05M | 13.35M | 2.01M |
Book Value Per Share | 0.22 | 8.80 | -34.51 | 42.16 | 202.30 | 37.40 |
Common Stock | 425 | 78 | 69 | 9.69K | 9.55K | 6.74K |
Retained Earnings | -67.31M | -58.54M | -54.02M | -44.07M | -29.19M | -16.83M |
Comprehensive Income | n/a | n/a | n/a | -14.88M | -14.88M | -14.88M |
Shareholders Equity | 733.21K | 3.97M | -2.59M | 3.05M | 13.35M | 2.01M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ALZN